no scripts enabled
Medikabazaar
Cart
Leugard 11.25 Depot Injection

Your Advantages

Brand Zydus

Leugard 11.25 Depot Injection contains Leuprolide Acetate 11.25 mg, a gonadotropin-releasing hormone (GnRH) agonist prescribed for the management of various hormone-dependent conditions.

 

Benefits

This medicine works by reducing the levels of certain hormones, such as testosterone in men and estrogen in women, which helps to slow the growth of hormone-sensitive cancer cells and manage other hormone-related disorders. It offers a sustained-release formulation, typically administered every three months, providing extended therapeutic support.

 

Uses and Indications

  • Prostate cancer.
  • Hormone-responsive breast cancer in women.
  • Endometriosis, including pain relief and reduction of lesions.
  • Uterine fibroids, often used with iron therapy for anemia.
  • Central precocious puberty in children.

The Leugard 11.25 Depot Injection contains:

  • Leuprolide Acetate 11.25 mg (active ingredient).
Active Ingredient(s)Leuprolide Acetate
Therapeutic ClassGonadotropin-Releasing Hormone (GnRH) Agonist
Route of AdministrationIntramuscular (IM) or Subcutaneous (SC) Injection
Storage ConditionsStore in a refrigerator (2°C - 8°C)
Regulatory ApprovalPrescription Required
Licensed IndicationsProstate cancer, Endometriosis, Uterine fibroids, Central precocious puberty

Dosage and Administration

  1. Leugard 11.25 Depot Injection is administered by a qualified healthcare professional, either as a subcutaneous or intramuscular injection.
  2. The typical dosage is one 11.25 mg injection given every three months (12 weeks).
  3. Your doctor will determine the appropriate dose and frequency based on your specific medical condition.
  4. Do not self-administer this medicine.

 

Storage and Disposal

  • Store this medicine in a refrigerator, between 2°C and 8°C.
  • Protect from light and keep in its original, tightly closed container.
  • Keep out of reach of children.

Precautions and Safety

  • Leugard 11.25 Depot Injection is contraindicated during pregnancy and breastfeeding; effective non-hormonal contraception should be used during treatment.
  • Long-term use may lead to a decrease in bone mineral density, increasing the risk of osteoporosis. Your doctor may recommend calcium and vitamin D supplements.
  • Inform your doctor about any history of alcohol use, smoking, or osteoporosis before starting treatment.
  • This medicine may cause dizziness or visual disturbances; exercise caution when driving or operating machinery.
  • Report any signs of depression, mood changes, or thoughts of suicide to your doctor immediately.
  • Hypersensitivity reactions, including anaphylaxis, have been reported. Seek immediate medical attention for severe allergic symptoms.

 

Side Effects and Risks

  • Common side effects include hot flashes, increased sweating, headache, mood swings, fatigue, and injection site reactions.
  • Other possible effects are weight changes, vaginal dryness or bleeding, decreased libido, bone or muscle pain, and difficulty sleeping.
  • Menstrual periods are expected to stop during treatment; inform your doctor if bleeding continues.
  • Initial worsening of symptoms may occur at the start of treatment.

 

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.

twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited